ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 34 filers reported holding ATYR PHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $676,000 | -20.2% | 1,845,873 | +19.8% | 0.00% | 0.0% |
| Q1 2019 | $847,000 | +24.9% | 1,540,559 | +12.6% | 0.00% | 0.0% |
| Q4 2018 | $678,000 | -24.6% | 1,367,959 | +23.6% | 0.00% | 0.0% |
| Q3 2018 | $899,000 | -40.6% | 1,107,025 | +20.1% | 0.00% | 0.0% |
| Q2 2018 | $1,514,000 | +47.3% | 921,961 | +137.6% | 0.00% | 0.0% |
| Q1 2018 | $1,028,000 | +5.1% | 388,100 | +38.9% | 0.00% | 0.0% |
| Q4 2017 | $978,000 | +68.6% | 279,400 | +143.2% | 0.00% | 0.0% |
| Q3 2017 | $580,000 | +182.9% | 114,900 | +90.5% | 0.00% | – |
| Q2 2017 | $205,000 | +50.7% | 60,300 | +55.4% | 0.00% | – |
| Q1 2017 | $136,000 | +65.9% | 38,800 | +1.8% | 0.00% | – |
| Q4 2016 | $82,000 | -62.7% | 38,100 | -44.9% | 0.00% | – |
| Q3 2016 | $220,000 | – | 69,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $5,813,000 | 6.14% |
| TANG CAPITAL MANAGEMENT LLC | 279,425 | $889,000 | 0.37% |
| JACKSON PARK CAPITAL, LLC | 66,000 | $210,000 | 0.27% |
| Rock Springs Capital Management LP | 433,500 | $1,379,000 | 0.09% |
| TIVERTON ASSET MANAGEMENT LLC | 213,748 | $680,000 | 0.06% |
| Quotient Investors, LLC | 22,200 | $71,000 | 0.05% |
| Alyeska Investment Group, L.P. | 1,040,135 | $3,308,000 | 0.03% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $253,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 138,962 | $442,000 | 0.01% |
| Magnetar Financial LLC | 138,459 | $440,000 | 0.01% |